Anxiogenic effects of nicotine in the dorsal hippocampus are mediated by 5-HT(1A) and not by muscarinic M1 receptors

Neuropharmacology

Volumn 39, Issue 2, 2000, Pages 300-307

  Kenny, Paul J ^a   Cheeta, Survjit ^a   E File, Sandra ^a  

^a NEUROSCIENCE RESEARCH CENTRE   (United Kingdom)

Author keywords

5 HT(1A) serotonergic receptors; Anxiety; Dorsal hippocampus; M1 muscarinic receptors; Nicotine; Social interaction test

Indexed keywords

[4 [(3 CHLOROPHENYL)CARBAMOYLOXY] 2 BUTYNYL]TRIMETHYLAMMONIUM; NICOTINE; PIRENZEPINE; SEROTONIN 1A RECEPTOR;

ANIMAL EXPERIMENT; ANXIETY; ARTICLE; DRUG EFFECT; DRUG RECEPTOR BINDING; HIPPOCAMPUS; LOCOMOTION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SOCIAL INTERACTION;

(4-(M-CHLOROPHENYLCARBAMOYLOXY)-2-BUTYNYL)TRIMETHYLAMMONIUM CHLORIDE; ANIMALS; ANXIETY; GANGLIONIC STIMULANTS; HIPPOCAMPUS; MALE; MUSCARINIC ANTAGONISTS; NICOTINE; PIPERAZINES; PIRENZEPINE; PYRIDINES; RATS; RECEPTOR, MUSCARINIC M1; RECEPTORS, MUSCARINIC; RECEPTORS, SEROTONIN; RECEPTORS, SEROTONIN, 5-HT1; SEROTONIN ANTAGONISTS;

EID: 0033989854     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0028-3908(99)00114-8     Document Type: Article

References (48)

1. Alkondon M., Albuquerque E.X. Diversity of nicotinicacetylchiline receptors in rat hippocampal neurons. I. Pharmacological and functional evidence for distinct structural subtypes. Journal of Pharmacology and Experimental Therapeutics. 265:1993;1455-1473.
2. Balfour D.J.K., Benwell M.E.M., Graham C.A., Vale A.L. Behavioural and adrenocortical responses to nicotine measured in rats with selective lesions of the 5-hydroxytryptaminergic fibres innervating the hippocampus. British Journal of Pharmacology. 89:1986;341-347.
3. Brioni J.D., O'Neill A.B., Kim D.J.B., Decker M.W. Nicotinic receptor agonists exhibit anxiolytic-like effects on the elevated plus-maze test. European Journal of Pharmacology. 283:1993;1-8.
4. Cao W., Burkholder T., Wilkins L., Collins A.C. A genetic comparison of the behavioral actions of ethanol and nicotine in the mirrored chamber. Pharmacology Biochemistry and Behavior. 45:1993;803-809.
5. 1A receptor antagonist, prevents the impairment of spatial learning caused by intrahippocampal administration of scopolamine or 7-chloro-kynurenic acid. Brain Research. 774:1997;167-174.
6. Cassel J.-C., Jeltsch H. Serotonergic modulation of cholinergic function in the central nervous system: cognitive implications. Neuroscience. 69:1995;1-41.
7. Clarke P.B.S., Kumar R. The effects of nicotine on locomotor activity in non-tolerant and tolerant rats. British Journal of Pharmacology. 78:1983;329-337.
8. Clarke P.B.S., Kumar C. Characterization of the locomotor stimulant action of nicotine in tolerant rats. British Journal of Pharmacology. 80:1983;587-594.
9. 3 receptor antagonist, RS-42358-197, in animal models of anxiety. European Journal of Pharmacology. 234:1993;91-99.
10. Curran H.V., Schifano F., Lader M. Models of memory dysfunction? A comparison of the effects of scopolamine and lorazepam on memory, psychomotor performance and mood. Psychopharmacology. 103:1991;83-90.
11. Damaj M.I., Glennon R.A., Martin B.R. Involvement of the serotonergic system in the hypoactive and antinociceptive effects of nicotine in mice. Brain Research Bulletin. 33:1994;199-203.
12. Decker M.W., Brioni J.D., Sullivan J.P., Buckley M.J., Radek R.J., Raszkiewicz J.L., Kang C.H., Kim D.J.B., Giardina W.J., Wasicak J.T., Garvey D.S., Williams M., Arneric S.P. (S)-3-methyl-5-(1-methyl-2-pyrrolindinyl) isoxazole (ABT 418): a novel cholinergic ligand with cognitive-enhancing and anxiolytic activities. II. In vivo characterization. Journal of Pharmacology and Experimental Therapeutics. 270:1994;319-328.
13. Decker, M.W., Curzon, P., Nikkel, A.L., Bitner, R.S, 1998. In vivo expression of alpha-4-containing nicotinic acetylcholine receptors on serotonergic neurons in brainstem nuclei of rat. Society for Neuroscience Abstracts 24:91.
14. File S.E. The use of social interaction as a method for detecting anxiolytic activity of chlordiazepoxide-like drugs. Journal of Neuroscience Methods. 2:1980;219-238.
15. 1A receptor modulation of anxiety in two ethological animal tests. The Journal of Neuroscience. 16:1996;4810-4815.
16. 1 receptors. Behavioral Neuroscience. 112:1998;352-359.
17. File S.E., Kenny P.J., Ouagazzal A. Bimodal modulation by nicotine of anxiety in the social interaction test: role of dorsal hippocampus. Behavioral Neuroscience. 112:1998;1423-1429.
18. File, S.E., Cheeta, S., Kenny, P.J. Ouagazzal, A.-M., Gonzalez, L.E., 1999. Roles of the dorsal raphé nucleus, lateral septum and the dorsal hippocampus in nicotine's effects on anxiety. Society for Neuroscience Abstracts (in press).
19. Hess C., Blozovski D. Hippocampal muscarinic cholinergic mediation of spontaneous alternation and fear in the developing rat. Behavioral Brain Research. 24:1987;203-214.
20. Hogg S., Andrews N., File S.E. Contrasting behavioural effects of 8-OH-DPAT in the dorsal raphé nucleus and ventral hippocampus. Neuropharmacology. 33:1994;343-348.
21. Iwamoto E.T. Antinociception after nicotine administration into the mesopontine tegmentum of rats: evidence for muscarinic actions. Journal of Pharmacology and Experimental Therapeutics. 251:1989;412-421.
22. Iwamoto E.T. Characterization of the antinociception induced by nicotine in the pedunculopontine tegmental nucleus and the nucleus raphe magnus. Journal of Pharmacology and Experimental Therapeutics. 257:1991;120-133.
23. 1A receptor enhances acetylcholine release in conscious rats. Journal of Neurochemistry. 62:1994;1804-1808.
24. Kanvt L., Stolerman I.P., Chandler C.J., Saigusa T., Pogun S. Influence of sex and female hormones on nicotine-induced changes in locomotor activity in rats. Pharmacology Biochemistry and Behavior. 62:1999;179-187.
25. 3]5-HT from rat hippocampal slices. Neuropharmacology. 35:1996;1769-1777.
26. Levin E.D. Nicotinic systems and cognitive function. Psychopharmacology. 108:1992;417-431.
27. 1B receptors mediating inhibition of acetylcholine release. European Journal of Pharmacology. 129:1986;333-337.
28. Mundy W.R., Iwamoto E.T. Nicotine impairs acquisition of radial-arm maze performance in rats. Pharmacology Biochemistry and Behavior. 40:1988;119-120.
29. O'Neill A.B., Brioni J.D. Benzodiazepine receptor mediation of the anxiolytic-like effect of (-)-nicotine in mice. Pharmacology Biochemistry and Behavior. 49:1994;755-757.
30. Ouagazzal A.-M., Kenny P.J., File S.E. Modulation of behavior on trials 1 and 2 in the elevated plus-maze test of anxiety after systemic and hippocampal administration of nicotine. Psychopharmacology. 141:1999;54-60.
31. Ouagazzal, A.-M., Kenny, P.J., File, S.E., 1999b. Stimulation of nicotinic receptors in the lateral septal nucleus increases anxiety. European Journal of Neuroscience (in press).
32. Paxinos G., Watson C.H. The Rat Brain in Stereotaxic Coordinates. 1986;London, Academic Press.
33. Raiteri M., Marchi M., Paudice P., Pittaluga A. Muscarinic receptors mediating inhibition of gamma-aminobutyric acid release in rat corpus striatum and their pharmacological characterization. Journal of Pharmacology and Experimental Therapeutics. 254:1990;496-501.
34. Reavill C., Stolerman I.P. Locomotor activity in rats after administration of nicotinic agonists intracerebrally. British Journal of Pharmacology. 99:1990;273-278.
35. Ribeiro E.B., Bettiker R.L., Bogdanov M., Wurtman R.J. Effects of systemic nicotine on serotonin release in rat brain. Brain Research. 621:1993;311-318.
36. 1A and nicotinic cholinergic receptors in the regulation of water maze navigation behavior. Brain Research. 649:1994;174-180.
37. Rodgers R.J., Cole J. Effects of scopolamine and its quaternary analogue in the murine elevated plus-maze test of anxiety. Behavioral Pharmacology. 6:1995;283-289.
38. Role L.W., Berg D.K. Nicotinic receptors in the development and modulation of CNS synapses. Neuron. 16:1996;1077-1085.
39. Rossner S., Schliebs R., Perez-Polo J.R., Wiley R.G., Bigl V. Differential changes in cholinergic markers from selected brain regions after specific immunolesion of the rat cholinergic basal forebrain system. Journal of Neuroscience Research. 40:1995;31-43.
40. Smythe J.W., Murphy D., Bhatnagar S., Timothy C., Costall B. Muscarinic antagonists are anxiogenic in rats tested in the black-white box. Pharmacology Biochemistry and Behavior. 54:1996;57-64.
41. Smythe J.W., Murphy D., Bhatnagar S., Timothy C., Costall B. The effects of intrahippocampal scopolamine infusions on anxiety in rats as measured by the black-white box test. Brain Research Bulletin. 45:1998;89-93.
42. Stolerman I.P., Mirza N.R., Shoaib M. Nicotine psychopharmacology: addiction, cognition and neuroadaptation. Medicinal Research Reviews. 15(1):1995;47-72.
43. 3 receptor antagonist ondansetron. Life Sciences. 61:1997;249-254.
44. Takada Y., Urano T., Ihara H., Takada A. Changes in the central and peripheral serotonergic system in rats exposed to water-immersion restrained stress and nicotine administration. Neuroscience Research. 23:1995;305-311.
45. Toth E., Sershen H., Hashim A., Vizi E.S., Lajtha A. Effect of nicotine on extracellular levels of neurotransmitters assessed by microdialysis in various brain regions: role of glutamic acid. Neurochemical Research. 17:1992;265-271.
46. Vazquez J., Guzman-Marin R., Salin-Pascual R., Drucker-Colin R. Transdermal nicotine on sleep and PGO spikes. Brain Research. 737:1996;317-320.
47. Wonnacott S. Pre-synaptic nicotinic ACh receptors. Trends in Neuroscience. 20:1997;92-98.
48. 2+]i in rat sublingual mucous acini by stimulating neurotransmitter release from pre-synaptic terminals. Proceedings of the Society for Experimental Biology and Medicine. 207:1994;292-301.